{{Rsnum
|rsid=806381
|Gene=CNR1
|Chromosome=6
|position=88156182
|Orientation=plus
|GMAF=0.3053
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CNR1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 44.2 | 46.0 | 9.7
| HCB | 45.3 | 46.0 | 8.8
| JPT | 47.8 | 46.0 | 6.2
| YRI | 54.4 | 40.8 | 4.8
| ASW | 45.6 | 40.4 | 14.0
| CHB | 45.3 | 46.0 | 8.8
| CHD | 57.8 | 36.7 | 5.5
| GIH | 41.6 | 42.6 | 15.8
| LWK | 52.7 | 40.9 | 6.4
| MEX | 51.7 | 37.9 | 10.3
| MKK | 51.9 | 38.3 | 9.7
| TSI | 50.0 | 42.2 | 7.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20587580
|Title=Polymorphisms in the endocannabinoid-receptor 1 in relation to fat mass distribution
}}

{{PMID Auto
|PMID=18375449
|Title=Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations.
}}

{{PMID Auto
|PMID=19886064
|Title=The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects.
}}

{{PMID Auto
|PMID=20838400
|Title=Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women?
}}

{{PMID Auto
|PMID=21480765
|Title=Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women.
}}

{{PMID Auto
|PMID=25136364
|Title=Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}